SRGA - Surgalign GAAP EPS of -$1.46 revenue of $20.2M; lowers outlook
- Surgalign press release ( NASDAQ: SRGA ): Q3 GAAP EPS of -$1.46.
- Revenue of $20.2M (-1.5% Y/Y).
- Company is lowering its full year 2022 revenue outlook to be in the range of $82 to $84 million. The Company now expects to have 10 to 15 sites secured by the end of the 2023 first quarter
For further details see:
Surgalign GAAP EPS of -$1.46, revenue of $20.2M; lowers outlook